Ancestral lysosomal enzymes with increased activity harbor therapeutic potential for treatment of Hunter syndrome

We show the successful application of ancestral sequence reconstruction to enhance the activity of iduronate-2-sulfatase (IDS), thereby increasing its therapeutic potential for the treatment of Hunter syndrome—a lysosomal storage disease caused by impaired function of IDS. Current treatment, enzyme...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendrikse, Natalie M., Sandegren, Anna, Andersson, Tommy, Blomqvist, Jenny, Makower, Åsa, Possner, Dominik, Su, Chao, Thalén, Niklas, Tjernberg, Agneta, Westermark, Ulrica, Rockberg, Johan, Svensson Gelius, Stefan, Syrén, Per-Olof, Nordling, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907806/
https://www.ncbi.nlm.nih.gov/pubmed/33665572
http://dx.doi.org/10.1016/j.isci.2021.102154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907806/
https://www.ncbi.nlm.nih.gov/pubmed/33665572
http://dx.doi.org/10.1016/j.isci.2021.102154

Ejemplares similares